Director of studies Sample Clauses

Director of studies. ‌ In collaboration with the boards of studies, the directors of studies are responsible for the practical organisation of degree programmes at the faculty. Heads of studies report to the vice-xxxx for education. Criteria for supplements for responsibilities Amount of supplement A supplement for responsibilities is granted for performing the duties of a director of studies for the degree programmes at Nat/Tech. The amount is the same as the classification in the circular7, and the size of the supplement is determined according to the number of student FTEs.8 • 150 FTEs DKK 13,600 • 151-599 FTEs DKK 21,100 • 600-1,199 FTEs DKK 61,100 • More than 1,200 FTEs DKK 87,300 However, an additional supplement of DKK 25,000 is granted for heads of studies with fewer than 600 FTEs. 7 Appendix 6 in Circular on the collective agreement for academics employed by the state (no. 043-19) 8 Student full-time equivalents (FTE) follow the academic year and are calculated on the HR website (link) each year to September.
Sample 1Sample 2
AutoNDA by SimpleDocs
Director of studies. ‌ The aim is for the director of studies to teach on the degree programme as part of his/her responsibilities on a regular basis. A supplement for responsibilities is granted for performing the function of director of studies for the degree programmes at Health. The size of the supplement is determined according to the number of student FTEs (Full Time Equivalents) on the basis of the rates in the collective agreement. Up to 150 student FTEs: DKK 38,600 151-599 student FTEs: DKK 46,600 600-1,199 student FTEs: DKK 61,100 More than 1,200 student FTEs DKK 87,300 It is possible for an employee to act as director of studies for more than one study programme. A supplement for responsibilities is granted regardless of the number of director of studies functions. If an employee performs multiple director of studies functions, the amount of the supplement for responsibilities is based on the total of student FTEs. A director of studies who performs this function at several departments is granted a supplement by the department at which he/she is employed. If the function of chair of the board of studies is also performed, a separate chair of the board of studies supplement is granted (see below).
Sample 1
Director of studies. (DOS) In consultation with the Director, the DOS provides leadership of the English Language Programs or University Entry Programs through course development, implementation, review, supervision, and the day to day running of the programs.
Sample 1
Director of studies. The aim is for the director of studies to teach on the degree programme as part of his/her responsibilities on a regular basis. A supplement for responsibilities is awarded for performing the function of director of studies for the degree programmes at Health. The size of the supplement is determined according to the number of student FTEs (Full Time Equivalents) on the basis of the rates in the collective agreement. Up to 150 student FTEs: DKK 38,600 151-599 student FTEs DKK 46,600 600-1,199 student FTEs DKK 61,100 More than 1,200 FTEs: DKK 87,300 It is possible for an employee to act as director of studies for more than one study programme. A supplement for responsibilities is awarded regardless of the number of director of studies functions. If an employee performs multiple director of studies functions, the amount of the supplement for responsibilities is based on the total of student FTEs. A director of studies who performs this function at several departments is awarded a supplement by the department at which he/she is employed. If the function of chair of the board of studies is also performed, a separate chair of the board of studies supplement is awarded (see below).
Sample 1

Related to Director of studies

  • Staffing Plan 8.l The Board and the Association agree that optimum class size is an important aspect of the effective educational program. The Polk County School Staffing Plan shall be constructed each year according to the procedures set forth in Board Policy and, upon adoption, shall become Board Policy.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK Firms and/or individuals that assisted in the development or drafting of the specifications, requirements, statements of work, or solicitation documents contained herein are excluded from competing for this solicitation. This shall not be applicable to firms and/or individuals providing responses to a publicly posted Request for Information (RFI) associated with a solicitation.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Construction Progress Meetings The Design Professional shall attend Construction Progress Meetings periodically held by the Contractor at the Site on a schedule determined by the Contractor. The Design Professional shall review the minutes of the meeting and provide his written comments to the minutes to the Owner and Contractor within seven calendar days after receipt of the meeting minutes.

  • Other Directory Services 73.10.1 Both parties acknowledge that CenturyLink’s directory publisher is not a party to this Agreement and that the provisions contained in this Agreement are not binding upon CenturyLink’s directory publisher.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Drug Plan 42.01 The parties agree to the continuation of the Drug Care plan as follows:

  • Progress Meetings The Engineer shall from time to time during the progress of the work confer with the State. The Engineer shall prepare and present such information as may be pertinent and necessary or as may be requested by the State in order to evaluate features of the work.

  • Additional Information for Product Development Projects Outcome of product development efforts, such copyrights and license agreements. • Units sold or projected to be sold in California and outside of California. • Total annual sales or projected annual sales (in dollars) of products developed under the Agreement. • Investment dollars/follow-on private funding as a result of Energy Commission funding. • Patent numbers and applications, along with dates and brief descriptions.  Additional Information for Product Demonstrations: • Outcome of demonstrations and status of technology. • Number of similar installations. • Jobs created/retained as a result of the Agreement.

  • Trials The Ship shall run the following test and trials:

Time is Money Join Law Insider Premium to draft better contracts faster.